openPR Logo
Press release

Asia-Pacific Prazosin Market Size, Share, Growth, Research and Forecast 2020-2026

08-13-2020 01:26 PM CET | Health & Medicine

Press release from: Orion Market Research

Asia-Pacific Prazosin Market Size, Share, Growth, Research

Asia-Pacific Asia-Pacific Prazosin Market is estimated to decline during the forecast period. However, some factors are positively influencing market growth to some extent. According to the European Society of Cardiology (ESC) in 2018, a report presented by a team of scientists suggested that one in five young adults in India has high blood pressure, which equals to nearly 80 million adults. The major risk factors for high blood pressure in the region include smoking, tobacco chewing, diabetes mellitus, and high cholesterol. Further, prazosin finds application in the treatment of various other conditions such as BPH, congestive heart failure, pheochromocytoma (adrenal gland tumor), sleep problems associated with PTSD; an anxiety disorder in people who experience or witness a traumatic, life-threatening event. However, due to the availability of alternatives the market for prazosin is projected to decline in the region.

A full report of Asia-Pacific Prazosin Market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-prazosin-market

Asia-Pacific Asia-Pacific Prazosin Market is segmented on the basis of application. Based on the application, the market is segmented into cardiovascular disease, neurological syndromes, prostate disorders, and kidney disorders. The CVD segment accounted for a significant share in the Asia-Pacific Asia-Pacific Prazosin Market. CVDs claim to take more lives each year than all forms of cancer and chronic lower respiratory diseases altogether. Thus, Prazosin is one of the treatments used for CVD mainly high BP and strokes. For instance, Minipress is specified for the treatment of hypertension, to control BP. Lowering blood pressure decreases the risk of fatal and nonfatal cardiovascular events, mainly strokes and myocardial infarction.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-prazosin-market

The companies which are contributing to the growth of the Asia-Pacific Asia-Pacific Prazosin Market include Ajinomoto Co., Inc., Standard Chem and Pharmaceuticals Co. Ltd., Sun Pharmaceuticals Industries Ltd., Merck KGaA, Mylan N.V., Pfizer Inc., and others. The market players are considerably contributing to the market by adopting various strategies including new product launch, merger, and acquisition, collaborations to stay competitive in the market.

Asia-Pacific Prazosin Market- Segmentation

By Application

• Cardiovascular Disease(CVD)
• Neurological Syndromes
• Prostate Disorders
• Kidney Disorders

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/asia-pacific-prazosin-market

Asia-Pacific Prazosin Market– Segment by Region

• China
• India
• Japan
• Rest of Asia-Pacific

Company Profiles

• Ajinomoto Co., Inc.
• Johnlee Pharmaceuticals Pvt. Ltd.
• Merck KGaA
• Pfizer Inc.
• R&D Systems Inc.
• Renata Ltd.
• Mylan N.V.
• Standard Chem and Pharmaceuticals Co. Ltd.
• Sun Pharmaceuticals Industries Ltd.
• Teva Pharmaceuticals Industries Ltd.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific Prazosin Market Size, Share, Growth, Research and Forecast 2020-2026 here

News-ID: 2111762 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Prazosin

Insights into the Global Prazosin Hydrochloride Market
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧: Welcome to our comprehensive blog on the Global Chamomile Extract Market. Chamomile, with its myriad of health benefits and soothing properties, has been a staple ingredient in herbal medicine and wellness products for centuries. In recent years, the demand for chamomile extract has surged significantly, driven by increasing consumer awareness regarding the health benefits of natural ingredients. This blog aims to delve into the various facets of the global chamomile extract
Insights into the Global Prazosin Hydrochloride Market: Exploring Trends and Opp …
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧: Welcome to our comprehensive analysis of the global Prazosin Hydrochloride market, covering its size, share, and the impact of COVID-19 on various aspects. Prazosin Hydrochloride, with CAS number 19237-84-4, has emerged as a crucial compound in the pharmaceutical industry due to its diverse applications. This blog aims to delve deep into the market dynamics, including resin type, application, technology, end-use industry, and regional forecasts spanning the period of 2023 to
Prazosin Market Trends, Segmentation, Growth, Analysis and Forecast 2023-2030
The global prazosin market is estimated to exhibit a negative CAGR of around 2% during the forecast period. Though the rise in CVDs due to high BP, increasing patient pool, and increasing awareness toward mental care are some of the positive factors for the growth of the market. However, due to the presence of alternative drugs, discontinuation of prazosin manufacturing by companies in the last decade, unfavorable reimbursement policies for
European Prazosin Market Growth, Analysis Report, Share, Trends and Overview 202 …
European prazosin market is estimated to decline during the forecast period. Additionally, according to the IHME (Institute for Health Metrics and Evaluation), in Western Europe, there was 3.92% share of the total population that was suffering from depression, 5.71% of the total population had an anxiety disorder and 0.94 % share of the population had bipolar disorder in 2017. Since one of the major applications of prazosin is for curing
China Prazosin Market Trends, Future Outlook, COVID-19 Impact Analysis, Forecast …
China prazosin market is estimated to decline during the forecast period. China is among the emerging nations facing a burden of the continuous increase in high blood pressure. Lack of physical activity, obese population, alcohol consumption, and smoking are some of the major factors that lead to the increasing incidences of high blood pressure. The rising aging population may further increase the risk of hypertension in China. As per the
US Prazosin Market Top Leading Players with Strategies and Forecast 2026
US prazosin market is estimated to decline during the forecast period. However, the country has a considerable share in the prazosin market due to the rise in the prevalence of the neurological disorder, heart disorders, kidney disorders, depressive disorders, and PTSD are some of the major factors that are making a considerable contribution to the growth of the prazosin market in the country. As per the US CDC (Centers for